Valuation: Guided Therapeutics, Inc.

Market Cap 23.17M 20.28M 18.7M 17.48M 32.92M 2.19B 33.64M 225M 86.93M 1.08B 87M 85.09M 3.75B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 26.04M 22.8M 21.03M 19.65M 37M 2.46B 37.82M 253M 97.72M 1.21B 97.8M 95.66M 4.22B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 day-16.63%
1 week-31.00%
Current month-12.62%
1 month-12.62%
3 months+0.30%
6 months-44.42%
Current year-62.94%
1 week 0.2
Extreme 0.2001
0.26
1 month 0.18
Extreme 0.1805
0.34
Current year 0.17
Extreme 0.17
0.54
1 year 0.12
Extreme 0.1231
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
6,272
Manager TitleAgeSince
Chief Executive Officer 70 2023-03-05
Chief Tech/Sci/R&D Officer 70 2010-12-01
Director TitleAgeSince
Director/Board Member 76 2006-04-09
Director/Board Member 69 2016-11-09
Director/Board Member 70 2016-11-30
Date Insider Type Main position Quantity % Market Cap.
Mar. 09Others

Director

10 0.9747%
Mar. 09Free

Chairman

110,000 0.1316%
Mar. 09Free

Director

110,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
-16.62%-31.00%-28.54%-21.53% 23.17M
-1.29%+9.00%+24.04%-0.73% 191B
+0.31%-0.20%-23.93%+21.92% 143B
-1.74%+8.81%-3.03%-17.89% 139B
-1.70%-4.00%-59.19%-18.65% 65.74B
+0.44%+4.37%+16.58%+0.82% 52.27B
-0.47%-0.50%-27.38%-32.98% 43.55B
-2.34%+4.54%+11.46%+14.14% 38.41B
-1.48%+3.78%+4.67%+43.28% 36.76B
-1.08%+5.62%-12.54%-15.73% 29.91B
Average -2.60%+2.41%-9.79%-2.73% 73.95B
Weighted average by Cap. -0.99%+5.58%-4.39%-0.59%

Financials

2024 2025
Net sales 7K 6.13K 5.65K 5.28K 9.94K 662K 10.16K 67.97K 26.26K 326K 26.29K 25.71K 1.13M 767K 671K 619K 579K 1.09M 72.5M 1.11M 7.45M 2.88M 35.77M 2.88M 2.82M 124M
Net income -2.42M -2.12M -1.95M -1.82M -3.43M -228M -3.51M -23.47M -9.07M -113M -9.08M -8.88M -391M -3.2M -2.8M -2.58M -2.41M -4.54M -302M -4.64M -31.03M -11.99M -149M -12M -11.74M -517M
Net Debt 1.77M 1.55M 1.43M 1.34M 2.52M 167M 2.57M 17.2M 6.64M 82.59M 6.65M 6.5M 287M 2.88M 2.52M 2.32M 2.17M 4.09M 272M 4.18M 27.93M 10.79M 134M 10.8M 10.56M 466M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
26-06-29 $0.2001 -16.62% 3,771
26-06-26 $0.2400 -7.69% 106
26-06-25 $0.2600 0.00% 101
26-06-23 $0.2600 -1.89% 14,600
  1. Stock Market
  2. Stocks
  3. GTHP Stock